Missed the live event? You can still watch for free
The full congress content is now available on-demand. Register online at no cost and gain access to all recorded keynote lectures, panel discussions, case studies, and industry symposia. Explore the latest insights at your convenience!
Content available until 31 August
About CaReMeLO
Cardiac disease, chronic kidney and liver disease and metabolic derangements like type 2 diabetes (T2DM) and their risk factors share etiologies and pathophysiologic mechanisms. These novel insights and their therapeutic implications have been recognized and adopted by cardiology, nephrology and endocrinology alike. Yet a need exists for a multidisciplinary scientific platform that unites all interested parties and serves as a unique gathering, devoting time to in-depth Cardiovascular, Renal, Liver, Metabolic and Obesity discussions.
The conference will continue to spotlight the pivotal role of family physicians in the integrated management of cardio-renal-metabolic (CRM) syndrome, steatotic liver disease, and obesity (CaReMeLO), with an enhanced focus on the SGLT2Inb, GLP-1R agonist and the dual GIPR/GLP-1R agonist.

Conference Highlights

In partnership with the
Polish Society of Family Medicine (PTMR)
